The management of melanoma patients with metastatic melanoma in the sentinel nodes (SN) is evolving based on the results of trials questioning the impact of completion lymph node dissection (CLND) and demonstrating the efficacy of new adjuvant treatments. In this landscape, new prognostic tools for fine risk stratification are eagerly sought to optimize the therapeutic path of these patients
Background. Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cu...
INTRODUCTION: Complete lymph node dissection (CLND) after a positive sentinel node (SN) biopsy provi...
Background and Purpose: Approximately 20% of melanoma patients harbor metastases in non-sentinel nod...
The management of melanoma patients with metastatic melanoma in the sentinel nodes (SN) is evolving ...
Background The management of melanoma patients with metastatic melanoma in the sentinel nodes (SN) i...
Introduction: Sentinel node (SN) biopsy (SNB) and completion lymph node dissection (CLND) when SN-po...
Background Data: The more intensive sentinel node (SN) pathologic workup, the higher the SN-positivi...
__Abstract__ The incidence and mortality of melanoma, the most malignant type of skin cancer, is ...
There are two hypotheses to explain melanoma dissemination: first, simultaneous lymphatic and hemato...
Recent data have demonstrated no survival benefit to immediate completion lymph node dissection (CLN...
BACKGROUND: Although widely used for the management of patients with cutaneous melanoma, the sentine...
Although widely used for the management of patients with cutaneous melanoma, the sentinel lymph node...
Background: In light of the evolving landscape of adjuvant therapy in melanoma and the recently conf...
International audienceBackground Sentinel lymph node (SLN) positivity has been found to be strongly...
PurposePrognosis in patients with sentinel node (SN) -positive melanoma correlates with several char...
Background. Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cu...
INTRODUCTION: Complete lymph node dissection (CLND) after a positive sentinel node (SN) biopsy provi...
Background and Purpose: Approximately 20% of melanoma patients harbor metastases in non-sentinel nod...
The management of melanoma patients with metastatic melanoma in the sentinel nodes (SN) is evolving ...
Background The management of melanoma patients with metastatic melanoma in the sentinel nodes (SN) i...
Introduction: Sentinel node (SN) biopsy (SNB) and completion lymph node dissection (CLND) when SN-po...
Background Data: The more intensive sentinel node (SN) pathologic workup, the higher the SN-positivi...
__Abstract__ The incidence and mortality of melanoma, the most malignant type of skin cancer, is ...
There are two hypotheses to explain melanoma dissemination: first, simultaneous lymphatic and hemato...
Recent data have demonstrated no survival benefit to immediate completion lymph node dissection (CLN...
BACKGROUND: Although widely used for the management of patients with cutaneous melanoma, the sentine...
Although widely used for the management of patients with cutaneous melanoma, the sentinel lymph node...
Background: In light of the evolving landscape of adjuvant therapy in melanoma and the recently conf...
International audienceBackground Sentinel lymph node (SLN) positivity has been found to be strongly...
PurposePrognosis in patients with sentinel node (SN) -positive melanoma correlates with several char...
Background. Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cu...
INTRODUCTION: Complete lymph node dissection (CLND) after a positive sentinel node (SN) biopsy provi...
Background and Purpose: Approximately 20% of melanoma patients harbor metastases in non-sentinel nod...